https://www.globenewswire.com/news-release/2025/01/16/3010565/28124/en/United-States-Influenza-Vaccines-Market-Research-2025-Featuring-Sanofi-Pasteur-GSK-Seqirus-AstraZeneca-Size-Shares-Data-Latest-Trends-Insights-Growth-Potential-CAGR-Forecasts-to-20.html
United States Influenza Vaccines Market Research 2025
The influenza vaccines market in the United States has experienced significant growth in recent years, driven by various factors including heightened...
united statesinfluenza vaccinesmarket research
https://globalhealth.georgetown.edu/publications/h5n1-influenza-vaccines-and-the-current-outbreak
H5N1 Influenza Vaccines and the Current Outbreak
On November 15, 2024, Georgetown University convened a webinar bringing together 20 experts from epidemiology, virology, vaccine development, regulatory...
influenza vaccinesand thecurrentoutbreak
https://pmc.ncbi.nlm.nih.gov/articles/PMC8475607/
Factors influencing the immunogenicity of influenza vaccines - PMC
Annual vaccination is the best prevention of influenza. However, the immunogenicity of influenza vaccines varies among different populations. It is important...
influenza vaccinesfactorsinfluencingimmunogenicitypmc
https://pmc.ncbi.nlm.nih.gov/articles/PMC8415297/
Live Attenuated Cold-Adapted Influenza Vaccines - PMC
Live attenuated, cold-adapted influenza vaccines exhibit several desirable characteristics, including the induction of systemic, mucosal, and cell-mediated...
influenza vaccineslivecoldadaptedpmc
https://pubmed.ncbi.nlm.nih.gov/27426005/
An overview of the regulation of influenza vaccines in the United States
Influenza virus vaccines are unique among currently licensed viral vaccines. The vaccines designed to protect against seasonal influenza illness must be...
an overviewof theinfluenza vaccinesregulationunited
https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/recombinant-influenza-vaccines-supplemental-statement-canadian-immunization-guide-seasonal-influenza-vaccine-2022-2023.html
Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter...
The objective of this statement is to review the available evidence on the efficacy, effectiveness, immunogenicity, and safety of Supemtek, and to provide...
influenza vaccines
https://health.economictimes.indiatimes.com/news/pharma/research-development/clinical-development-of-universal-influenza-vaccines-gaining-precedence-globaldata/101014208
Clinical development of universal influenza vaccines gaining precedence: GlobalData, ETHealthworld
Globaldata: The current influenza vaccines only provide protection against a limited number of strains, with the strains predicted to be dominant in the...
clinical developmentinfluenza vaccinesuniversalgainingprecedence
https://nutritionmatters.substack.com/p/influenza-vaccines-do-not-reduce-1da
Influenza vaccines do not reduce hospitalisations or deaths (Part 2)
Confirmation of Anderson et al. 2020 findings that on average, vaccination of 65 year olds does not directly help them.
influenza vaccinesdo notreducehospitalisationsdeaths
https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/annual-update-seasonal-influenza-vaccines.html
Guidance document: Annual update of seasonal influenza vaccines - Canada.ca
Guidance document: Annual update of seasonal influenza vaccines
guidance documentannual updateseasonal influenzavaccinescanada
https://collections.nlm.nih.gov/?f%5Bdrep2.subjectAggregate%5D%5B%5D=Influenza+Vaccines+--+therapeutic+use
Subjects: Influenza Vaccines -- therapeutic use - Digital Collections - National Library of...
influenza vaccinestherapeutic usedigital collectionsnational librarysubjects
https://ivr.cidrap.umn.edu/rd-progress/vaccinology-seasonal-influenza-vaccines
Vaccinology for Seasonal Influenza Vaccines | CIDRAP
CIDRAP provides advice, information and analysis on the prevention, control and treatment of targeted infectious diseases and in public health preparedness.
seasonal influenzavaccinologyvaccinescidrap
https://www.sciencedaily.com/releases/2010/02/100216203146.htm
Influenza vaccines: Poor evidence for effectiveness in elderly | ScienceDaily
Evidence for the safety and efficacy of influenza vaccines in the over-65s is poor, despite the fact that vaccination has been recommended for the prevention...
influenza vaccinespoorevidenceeffectivenesselderly
https://familiesfightingflu.org/
Influenza Information | Symptoms, Vaccines, Risks
Influenza, or the 'flu' is a highly contagious viral infection. Browse our influenza information to learn about symptoms, risks and treatment for all ages.
influenza informationsymptomsvaccinesrisks
https://pmc.ncbi.nlm.nih.gov/articles/PMC6491174/
Vaccines for preventing influenza in healthy children - PMC
The consequences of influenza in children and adults are mainly absenteeism from school and work. However, the risk of complications is greatest in children...
healthy childrenvaccinespreventinginfluenzapmc
https://edoc.ub.uni-muenchen.de/22917/
Development and evaluation of double-attenuated influenza A live vaccines in swine
https://www.cdc.gov/vaccines/hcp/by-disease/flu.html
Seasonal Influenza (Flu) Vaccination Information for Health Care Providers | Vaccines &...
Flu vaccine info for providers, including recommendations, storage, handling, and administration.
for health care providersflu vaccination informationseasonal influenzavaccines
https://www.rug.nl/research/medical-microbiology/moleculairevirologie/newsitems/patil
PhD ceremony Mr. H.P. Patil: Development of adjuvanted influenza vaccines for pulmonary delivery |...
May 9, 2019 - Promotion Harshad Patil
https://www.cdc.gov/MMWR/preview/mmwrhtml/mm5138a7.htm
Notice to Readers: Expansion of Eligibility for Influenza Vaccine Through the Vaccines for Children...
notice to readers
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5848a4.htm?s_cid=mm5848a4_e
Safety of Influenza A (H1N1) 2009 Monovalent Vaccines --- United States, October 1--November 24,...
https://www.cdc.gov/mmwr/volumes/72/wr/mm7251a3.htm?s_cid=mm7251a3_w%20
Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing...
Dec 21, 2023 - This report describes respiratory syncytial virus, influenza, and COVID-19 vaccination coverage among nursing home residents.
respiratory syncytial virus
https://health.ec.europa.eu/latest-updates/upcoming-eu4health-calls-tenders-advancing-influenza-and-mpox-vaccines-and-antimicrobial-2025-03-04_en
Upcoming EU4Health calls for tenders: advancing influenza and mpox vaccines, and antimicrobial...
Upcoming EU4Health calls for tenders: advancing influenza and mpox vaccines, and antimicrobial susceptibility testing
calls for tendersupcoming
https://www.rug.nl/research/medical-microbiology/moleculairevirologie/newsitems/patil?lang=en
PhD ceremony Mr. H.P. Patil: Development of adjuvanted influenza vaccines for pulmonary delivery |...
May 9, 2019 - Promotion Harshad Patil
https://www.techtransfer.nih.gov/patent/e-195-2014-0-cn-03
Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines | Technology Transfer
influenza virus
https://www.cdc.gov/flu-vaccines-work/php/vaccine-effectiveness/haiven.html
Hospitalized Adult Influenza Vaccine Effectiveness Network | Flu Vaccines Work | CDC
The HAIVEN network estimates VE against severe flu illness, especially in older adults.
influenza vaccinevaccines workhospitalizedadulteffectiveness
https://pubmed.ncbi.nlm.nih.gov/26232121/
[Influenza vaccination. Effectiveness of current vaccines and future challenges]
Seasonal influenza is an annual challenge for health-care systems, due to factors such as co-circulation of 2 influenza A subtypes jointly with 2 influenza B...
influenza vaccinationeffectivenesscurrentvaccinesfuture
https://pubmed.ncbi.nlm.nih.gov/41851138/
Lysosome-targeting live attenuated influenza vaccines elicit robust and broad immunity in mice
The lysosome is a cell's endogenous machinery responsible for degrading proteins. Here we describe two lysosome-targeting live attenuated vaccine approaches,...
https://pubmed.ncbi.nlm.nih.gov/32392457/
Challenges of Making Effective Influenza Vaccines
Seasonal influenza vaccines prevent influenza-related illnesses, hospitalizations, and deaths. However, these vaccines are not as effective as other viral...
challengesmakingeffectiveinfluenzavaccines
https://kidshealth.org/CHOC/en/parents/flu-vaccine.html
Your Child's Vaccines: Influenza (Flu) Vaccine (for Parents) - CHOC Childrens
Find out when and why kids need to get the flu vaccine.
your childflu vaccinefor parentsvaccinesinfluenza
https://www.prnewswire.com/news-releases/texas-biomed-researching-vaccines-and-treatments-for-highly-pathogenic-avian-influenza-302120203.html
Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza
/PRNewswire/ -- Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly...
treatments fortexasbiomedresearchingvaccines
https://www.cdc.gov/flu/vaccines/coadministration.html
Getting a Flu Vaccine and other Recommended Vaccines at the Same Time | Influenza (Flu) | CDC
You can get a flu vaccine with other recommended vaccines at the same visit if you are due.
at the same time
https://pubmed.ncbi.nlm.nih.gov/27255748/
Influenza virus neuraminidase (NA): a target for antivirals and vaccines
Influenza, the most common infectious disease, poses a great threat to human health because of its highly contagious nature and fast transmissibility, often...
influenza virusnatargetantiviralsvaccines
https://pubmed.ncbi.nlm.nih.gov/22346299/?dopt=Abstract
Influenza update: a review of currently available vaccines
Influenza update: a review of currently available vaccines
a reviewcurrently availableinfluenzaupdatevaccines
https://www.sciencedaily.com/releases/2014/01/140106190048.htm
Brief fever common in kids given influenza, pneumococcal vaccines together | ScienceDaily
Giving young children the influenza and pneumococcal vaccines together appears to increase their risk of fever, according to a study that looked at children...
in kidspneumococcal vaccinesbrieffevercommon
https://www.cslseqirus.ca/
CSL Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
csl seqirusworld leaderinfluenzavaccines
https://makisw.substack.com/p/mrna-injury-series-dying-from-influenza?open=false
mRNA Injury series - Dying from Influenza, pneumonia - COVID-19 mRNA Vaccines severely damage the...
Nov.21, 2023 (photos above) - Brazil - 38 year old news anchor Elaine da Silva was 23 weeks pregnant and was sent to hospital in Sao Paulo, Brazil on Monday...
https://www.mdpi.com/2076-393X/8/4/704
Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than...
Background: vaccination is the best approach to prevent influenza infections so far. Serological studies on the effect of different vaccine types are important...
https://pubmed.ncbi.nlm.nih.gov/40266236/
The Effectiveness of Four Quadrivalent, Inactivated Influenza Vaccines Administered Alone or in...
https://www.techtransfer.nih.gov/patent/e-323-2005-1-us-01
Vaccines Against Potential Pandemic Strains Of Influenza | Technology Transfer
vaccinespotentialpandemicstrainsinfluenza
https://www.techtransfer.nih.gov/patent/e-032-2019-0-kr-06
NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF | Technology Transfer
influenza virusnanoparticlebasedvaccinesuses
https://www.techtransfer.nih.gov/patent/e-195-2014-0-us-01
Polyvalent Influenza Virus-Like Particles (VLPs) And Use as Vaccines | Technology Transfer
influenza virus
https://www.cslseqirus.us/
CSL Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
csl seqirusworld leaderinfluenzavaccines
https://www.techtransfer.nih.gov/patent/e-293-2011-2-it-14
NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES | Technology Transfer
novelinfluenzaproteinbasedvaccines
https://www.influenza.spb.ru/en/institute/structure/department-of-vaccinology/laboratory-of-influenza-vaccines/
Laboratory of Influenza Vaccines
laboratoryinfluenzavaccines
https://www.techtransfer.nih.gov/patent/e-019-2007-2-us-11
Vaccines Against Potential Pandemic Strains Of Influenza | Technology Transfer
vaccinespotentialpandemicstrainsinfluenza
https://www.techtransfer.nih.gov/patent/e-293-2011-3-us-01
NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES | Technology Transfer
novelinfluenzaproteinbasedvaccines
https://www.cdc.gov/flu/professionals/acip/other-vaccines.htm
Concurrent Administration of Influenza Vaccine With Other Vaccines | CDC
Concurrent Administration of Influenza Vaccine With Other Vaccines - CDC
influenza vaccineother vaccinesconcurrentadministrationcdc
https://www.mdpi.com/2076-393X/8/4/756
Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian...
A series of commercial inactivated influenza vaccines (IIVs) used in the Russian National Immunization Program were characterized to evaluate their protective...
study in
https://influenza.spb.ru/en/institute/structure/department-of-vaccinology/laboratory-of-influenza-vaccines/
Laboratory of Influenza Vaccines
laboratoryinfluenzavaccines
https://cordis.europa.eu/project/id/324634
ARCAS: Analysis of the Route to Commercialisation of MVA based influenza vaccines | ARCAS | Project...
ARCAS will investigate the commercial potential and commercialization strategy of a platform of continuously updated repository of pandemic influenza vaccine...
of the
https://www.cslseqirus.co.uk/
CSL Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
csl seqirusworld leaderinfluenzavaccines
https://pubmed.ncbi.nlm.nih.gov/33172191/
New Technologies for Influenza Vaccines
Vaccine development has been hampered by the long lead times and the high cost required to reach the market. The 2020 pandemic, caused by a new coronavirus...
new technologiesinfluenzavaccines
https://www.cslseqirus.co.nz/
CSL Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
csl seqirusworld leaderinfluenzavaccines
https://globalnews.ca/video/10085753/over-1-million-influenza-vaccines-administered-already-dr-bonnie-henry-says
Over 1 million influenza vaccines administered already, Dr. Bonnie Henry says | Watch News Videos...
Watch Over 1 million influenza vaccines administered already, Dr. Bonnie Henry says Video Online, on GlobalNews.ca
https://pmc.ncbi.nlm.nih.gov/articles/PMC6491101/
Vaccines for preventing influenza in the elderly - PMC
The consequences of influenza in the elderly (those age 65 years or older) are complications, hospitalisations, and death. The primary goal of influenza...
in thevaccinespreventinginfluenzaelderly